» Articles » PMID: 22914093

Antibiotics in Early Life Alter the Murine Colonic Microbiome and Adiposity

Overview
Journal Nature
Specialty Science
Date 2012 Aug 24
PMID 22914093
Citations 751
Authors
Affiliations
Soon will be listed here.
Abstract

Antibiotics administered in low doses have been widely used as growth promoters in the agricultural industry since the 1950s, yet the mechanisms for this effect are unclear. Because antimicrobial agents of different classes and varying activity are effective across several vertebrate species, we proposed that such subtherapeutic administration alters the population structure of the gut microbiome as well as its metabolic capabilities. We generated a model of adiposity by giving subtherapeutic antibiotic therapy to young mice and evaluated changes in the composition and capabilities of the gut microbiome. Administration of subtherapeutic antibiotic therapy increased adiposity in young mice and increased hormone levels related to metabolism. We observed substantial taxonomic changes in the microbiome, changes in copies of key genes involved in the metabolism of carbohydrates to short-chain fatty acids, increases in colonic short-chain fatty acid levels, and alterations in the regulation of hepatic metabolism of lipids and cholesterol. In this model, we demonstrate the alteration of early-life murine metabolic homeostasis through antibiotic manipulation.

Citing Articles

Human gut microbial aromatic amino acid and related metabolites prevent obesity through intestinal immune control.

Jiang Z, He L, Li D, Zhuo L, Chen L, Shi R Nat Metab. 2025; .

PMID: 40087408 DOI: 10.1038/s42255-025-01246-5.


The effects of ursodeoxycholic acid on cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled trials.

Rashidbeygi E, Rasaei N, Amini M, Salavatizadeh M, Mohammadizadeh M, Hekmatdoost A BMC Cardiovasc Disord. 2025; 25(1):125.

PMID: 39984850 PMC: 11844182. DOI: 10.1186/s12872-025-04549-3.


Machine learning prediction of obesity-associated gut microbiota: identifying as a potential therapeutic target.

Wu H, Li Y, Jiang Y, Li X, Wang S, Zhao C Front Microbiol. 2025; 15:1488656.

PMID: 39974372 PMC: 11839209. DOI: 10.3389/fmicb.2024.1488656.


Early-life antibiotic exposure aggravates hepatic steatosis through enhanced endotoxemia and lipotoxic effects driven by gut .

Zhang X, Chan D, Zhu J, Sin D, Peng Y, Wong M MedComm (2020). 2025; 6(3):e70104.

PMID: 39968496 PMC: 11832435. DOI: 10.1002/mco2.70104.


Rurality and relative poverty drive acquisition of a stable and diverse gut microbiome in early childhood in a non-industrialized setting.

Seco-Hidalgo V, Witney A, Chico M, Vaca M, Arevalo A, Schuyler A Sci Rep. 2025; 15(1):5601.

PMID: 39955323 PMC: 11830098. DOI: 10.1038/s41598-025-89224-5.


References
1.
Dethlefsen L, Relman D . Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2010; 108 Suppl 1:4554-61. PMC: 3063582. DOI: 10.1073/pnas.1000087107. View

2.
Bergman E . Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev. 1990; 70(2):567-90. DOI: 10.1152/physrev.1990.70.2.567. View

3.
Wong J, de Souza R, Kendall C, Emam A, Jenkins D . Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006; 40(3):235-43. DOI: 10.1097/00004836-200603000-00015. View

4.
Gesta S, Tseng Y, Kahn C . Developmental origin of fat: tracking obesity to its source. Cell. 2007; 131(2):242-56. DOI: 10.1016/j.cell.2007.10.004. View

5.
Yamada Y, Seino Y . Physiology of GIP--a lesson from GIP receptor knockout mice. Horm Metab Res. 2005; 36(11-12):771-4. DOI: 10.1055/s-2004-826162. View